Transscleral drug delivery to the posterior eye: prospects of pharmacokinetic modeling.

Basic biological research has provided new approaches to treat severe diseases of the retina and choroid, such as age related macular degeneration. Although it is possible to deliver drugs from a subconjunctival drug depot to the retina and choroid, the barriers and kinetics of this route of drug administration are not well known. In this review we investigate the pharmacokinetic aspects of transscleral drug delivery into the posterior eye with emphasis on pharmacokinetic modeling. The existing simulation models related to the transscleral drug delivery are reviewed and future directions for the model development are discussed. In addition, a new simulation model for the transscleral drug delivery based on permeability data is introduced. This compartmental model contains several ocular tissues (sclera, choroid, retinal pigment epithelium and vitreous) and it takes into account the clearance of the drug via choroidal circulation. The model is used to simulate the vitreous delivery of macromolecules based on the available data on FITC-dextran 70 kDa.

[1]  J. V. van Meurs,et al.  High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection. , 1999, American journal of ophthalmology.

[2]  D. Maurice,et al.  The active transport of fluorescein by the retinal vessels and the retina , 1967, The Journal of physiology.

[3]  R W Bellhorn,et al.  Permeability of blood-ocular barriers of neonatal and adult cats to fluorescein-labeled dextrans of selected molecular sizes. , 1981, Investigative ophthalmology & visual science.

[4]  Clive G. Wilson,et al.  Topical and systemic drug delivery to the posterior segments. , 2005, Advanced drug delivery reviews.

[5]  A. Harris,et al.  Do sex and hormonal status influence choroidal circulation? , 2000, The British journal of ophthalmology.

[6]  J. Robinson,et al.  Drug delivery to the posterior segment of the eye II: development and validation of a simple pharmacokinetic model for subconjunctival injection. , 2004, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[7]  J. Robinson,et al.  Drug delivery to the posterior segment of the eye: some insights on the penetration pathways after subconjunctival injection. , 2001, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[8]  M. Prausnitz,et al.  Measurement and prediction of lateral diffusion within human sclera. , 2006, Investigative ophthalmology & visual science.

[9]  Kakuji Tojo,et al.  A pharmacokinetic model for ocular drug delivery. , 2004, Chemical & pharmaceutical bulletin.

[10]  H. Boxenbaum,et al.  Pharmacokinetics: philosophy of modeling. , 1992, Drug metabolism reviews.

[11]  S. Eguchi,et al.  Movement of fluorescein and its glucuronide across retinal pigment epithelium-choroid. , 1993, Investigative ophthalmology & visual science.

[12]  J. Marshall,et al.  Human retinal molecular weight exclusion limit and estimate of species variation. , 2003, Investigative ophthalmology & visual science.

[13]  Elizabeth M. Topp,et al.  Transport processes in pharmaceutical systems , 1999 .

[14]  Y. Ogura,et al.  Biodegradable intrascleral implant for sustained intraocular delivery of betamethasone phosphate. , 2003, Investigative ophthalmology & visual science.

[15]  J. Robinson,et al.  Mechanisms of anterior segment absorption of pilocarpine following subconjunctival injection in albino rabbits. , 1980, Journal of pharmaceutical sciences.

[16]  A. Bill,et al.  Physiology of the choroidal vascular bed , 1983, International Ophthalmology.

[17]  Jennifer I. Lim,et al.  Human scleral permeability. Effects of age, cryotherapy, transscleral diode laser, and surgical thinning. , 1995, Investigative ophthalmology & visual science.

[18]  B. Schlosshauer,et al.  Functional characterization and comparison of the outer blood-retina barrier and the blood-brain barrier. , 2005, Investigative ophthalmology & visual science.

[19]  R. Huupponen,et al.  Timolol binding to bovine ocular melanin in vitro. , 1988, Journal of ocular pharmacology.

[20]  R. Flower,et al.  Theoretical investigation of the role of choriocapillaris blood flow in treatment of subfoveal choroidal neovascularization associated with age-related macular degeneration. , 2001, American journal of ophthalmology.

[21]  J. Marshall,et al.  Age-related alterations in the diffusional transport of amino acids across the human Bruch's-choroid complex. , 2002, Journal of the Optical Society of America. A, Optics, image science, and vision.

[22]  H. Edelhauser,et al.  In Vitro Sustained Human Transscleral Drug Delivery of Fluorescein-Labeled Dexamethasone and Methotrexate with Fibrin Sealant , 2005, Current eye research.

[23]  E S Gragoudas,et al.  Diffusion of high molecular weight compounds through sclera. , 2000, Investigative ophthalmology & visual science.

[24]  E. Jeong,et al.  Assessment of Subconjunctival Delivery with Model Ionic Permeants and Magnetic Resonance Imaging , 2004, Pharmaceutical Research.

[25]  G. Chader,et al.  PHARMACOLOGY OF THE EYE , 1984, Handbook of Experimental Pharmacology.

[26]  P. Missel.  Finite and Infinitesimal Representations of the Vasculature: Ocular Drug Clearance by Vascular and Hydraulic Effects , 2004, Annals of Biomedical Engineering.

[27]  G. Raviola.  Conjunctival and episcleral blood vessels are permeable to blood-borne horseradish peroxidase. , 1983, Investigative ophthalmology & visual science.

[28]  Safety of posterior juxtascleral depot administration of the angiostatic cortisene anecortave acetate for treatment of subfoveal choroidal neovascularization in patients with age-related macular degeneration , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.

[29]  I. Tamai,et al.  Intraocular penetration kinetics of prednisolone after subconjunctival injection in rabbits. , 1988, Ophthalmic research.

[30]  Aki Kato,et al.  Effect of benzalkonium chloride on transscleral drug delivery. , 2005, Investigative ophthalmology & visual science.

[31]  Arto Urtti,et al.  Challenges and obstacles of ocular pharmacokinetics and drug delivery. , 2006, Advanced drug delivery reviews.

[32]  K Miyamoto,et al.  Transscleral delivery of bioactive protein to the choroid and retina. , 2000, Investigative ophthalmology & visual science.

[33]  N. D. Levine,et al.  Orbital infusion of steroids in the rabbit. , 1970, Archives of ophthalmology.

[34]  P. Törnquist.  Capillary permeability in cat choroid, studied with the single injection technique (II). , 1979, Acta physiologica Scandinavica.

[35]  Y. Ogura,et al.  Intraocular tissue distribution of betamethasone after intrascleral administration using a non-biodegradable sustained drug delivery device. , 2003, Investigative ophthalmology & visual science.

[36]  A. Bill.  MOVEMENT OF ALBUMIN AND DEXTRAN THROUGH THE SCLERA. , 1965, Archives of ophthalmology.

[37]  A. Alm,et al.  Ocular and optic nerve blood flow at normal and increased intraocular pressures in monkeys (Macaca irus): a study with radioactively labelled microspheres including flow determinations in brain and some other tissues. , 1973, Experimental eye research.

[38]  P. Missel,et al.  Dissolution of Anecortave Acetate in a Cylindrical Flow Cell: Re‐Evaluation of Convective Diffusion/Drug Dissolution for Sparingly Soluble Drugs , 2005, Pharmaceutical development and technology.

[39]  V. Kinsey.  Ion Movement in the Eye , 1960, Circulation.

[40]  J. Marshall,et al.  Compartmental analysis of taurine transport to the outer retina in the bovine eye. , 2004, Investigative ophthalmology & visual science.

[41]  U. Kompella,et al.  Periocular routes for retinal drug delivery , 2004, Expert opinion on drug delivery.

[42]  M. Barza.  Antibacterial agents in the treatment of ocular infections. , 1989, Infectious disease clinics of North America.

[43]  A. Alm,et al.  Permeability of the intraocular blood vessels. , 1980, Transactions of the ophthalmological societies of the United Kingdom.

[44]  Y. Ogura,et al.  Feasibility of drug delivery to the posterior pole of the rabbit eye with an episcleral implant. , 2004, Investigative ophthalmology & visual science.

[45]  P. Jong.  Prevalence of age-related macular degeneration in the United States. , 2004 .

[46]  J. V. van Meurs,et al.  Intraocular penetration and systemic absorption after topical application of dexamethasone disodium phosphate. , 2002, Ophthalmology.

[47]  I. Klock,et al.  Zonulae adherentes pore size in the external limiting membrane of the rabbit retina. , 1985, Investigative ophthalmology & visual science.

[48]  D. Maurice,et al.  The loss of fluorescein, fluorescein glucuronide and fluorescein isothiocyanate dextran from the vitreous by the anterior and retinal pathways. , 1991, Experimental eye research.

[49]  Jonghyeon Kim,et al.  A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide. , 2006, Experimental eye research.

[50]  E. Gragoudas,et al.  Angiography of fluoresceinated anti-vascular endothelial growth factor antibody and dextrans in experimental choroidal neovascularization. , 2000, Archives of ophthalmology.

[51]  J. Baum,et al.  Pharmacokinetics of newer cephalosporins after subconjunctival and intravitreal injection in rabbits. , 1993, Archives of ophthalmology.

[52]  K. Tojo,et al.  Pharmacokinetic model of intravitreal drug injection. , 1994, Mathematical Biosciences.

[53]  Nam Sun Wang,et al.  Study of Ocular Transport of Drugs Released from an Intravitreal Implant Using Magnetic Resonance Imaging , 2005, Annals of Biomedical Engineering.

[54]  Thomas M. Aaberg,et al.  Transscleral permeability and intraocular concentrations of cisplatin from a collagen matrix , 2003 .

[55]  S. Tseng,et al.  Paracellular permeability of corneal and conjunctival epithelia. , 1989, Investigative ophthalmology & visual science.

[56]  Taro Ogiso,et al.  Polar Solute Transport Across the Pigmented Rabbit Conjunctiva: Size Dependence and the Influence of 8-Bromo Cyclic Adenosine Monophosphate , 1997, Pharmaceutical Research.

[57]  O. Candia,et al.  Spontaneous fluid transport across isolated rabbit and bovine ciliary body preparations. , 2005, Investigative ophthalmology & visual science.

[58]  E. Ng,et al.  Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration. , 2005, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[59]  Uday B Kompella,et al.  Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression. , 2003, Investigative ophthalmology & visual science.

[60]  A. Bill.  Capillary permeability to and extravascular dynamics of myoglobin, albumin and gammaglobulin in the uvea. , 1968, Acta physiologica Scandinavica.

[61]  M. Prausnitz,et al.  Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. , 1998, Journal of pharmaceutical sciences.

[62]  C. P. Wilkinson,et al.  Differences in pulsatile ocular blood flow among three classifications of diabetic retinopathy. , 2004, Investigative ophthalmology & visual science.

[63]  F. Johnson,et al.  A simple method of measuring aqueous humor flow with intravitreal fluoresceinated dextrans. , 1984, Experimental eye research.

[64]  U. Kompella,et al.  Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model. , 2005, European journal of pharmacology.

[65]  U. Kompella,et al.  Retinal Delivery of Celecoxib Is Several-Fold Higher Following Subconjunctival Administration Compared to Systemic Administration , 2004, Pharmaceutical Research.

[66]  N. Morlet,et al.  High dose intravitreal ganciclovir injection provides a prolonged therapeutic intraocular concentration. , 1996, The British journal of ophthalmology.

[67]  G. Clover,et al.  The effect of age on the macromolecular permeability of human Bruch's membrane. , 2001, Investigative ophthalmology & visual science.

[68]  Kati-Sisko Vellonen,et al.  Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics. , 2006, Advanced drug delivery reviews.

[69]  B. Saville,et al.  Drug distribution in the vitreous humor of the human eye: the effects of intravitreal injection position and volume. , 1997, Current eye research.

[70]  A. Bill.  THE DRAINAGE OF ALBUMIN FROM THE UVEA. , 1964, Experimental eye research.

[71]  H. Holzhütter,et al.  A Compartment Model to Calculate Time-dependent Concentration Profiles of Topically Applied Chemical Compounds in the Anterior Compartments of the Rabbit Eye , 2001, Alternatives to laboratory animals : ATLA.

[72]  G E Trope,et al.  Quantitative determination of the melanin contents in ocular tissues from human blue and brown eyes. , 1992, Journal of ocular pharmacology.

[73]  A. Urtti,et al.  Permeability of retinal pigment epithelium: effects of permeant molecular weight and lipophilicity. , 2005, Investigative ophthalmology & visual science.

[74]  M. Prausnitz,et al.  Fiber matrix model of sclera and corneal stroma for drug delivery to the eye , 1998 .

[75]  J. V. van Meurs,et al.  Dexamethasone concentration in vitreous and serum after oral administration. , 1998, American journal of ophthalmology.

[76]  M F Marmor,et al.  Kinetics of macromolecules injected into the subretinal space. , 1985, Experimental eye research.

[77]  K. Kontturi,et al.  Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera. , 1997, Investigative ophthalmology & visual science.

[78]  A. Edwards,et al.  A model of glucose transport and conversion to lactate in the renal medullary microcirculation. , 2006, American journal of physiology. Renal physiology.

[79]  M. Prausnitz,et al.  Measurement and Prediction of Transient Transport across Sclera for Drug Delivery to the Eye , 1998 .

[80]  Hyuncheol Kim,et al.  Controlled drug release from an ocular implant: an evaluation using dynamic three-dimensional magnetic resonance imaging. , 2004, Investigative ophthalmology & visual science.

[81]  K. Tojo,et al.  A pharmacokinetic model of intravitreal delivery of ganciclovir. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[82]  P. Campochiaro.  Potential applications for RNAi to probe pathogenesis and develop new treatments for ocular disorders , 2006, Gene Therapy.

[83]  B. Saville,et al.  Finite element modeling of drug distribution in the vitreous humor of the rabbit eye , 1997, Annals of Biomedical Engineering.

[84]  V. H. Lee,et al.  Lipophilicity influence on conjunctival drug penetration in the pigmented rabbit: a comparison with corneal penetration. , 1991, Current eye research.

[85]  P. Missel.  Hydraulic Flow and Vascular Clearance Influences on Intravitreal Drug Delivery , 2002, Pharmaceutical Research.

[86]  J. V. van Meurs,et al.  Intravitreal vancomycin and gentamicin concentrations in patients with postoperative endophthalmitis , 2001, The British journal of ophthalmology.

[87]  T. Aaberg,et al.  Transscleral diffusion of carboplatin: an in vitro and in vivo study. , 2002, Archives of ophthalmology.

[88]  J. Robinson,et al.  Drug delivery to the posterior segment of the eye III: the effect of parallel elimination pathway on the vitreous drug level after subconjunctival injection. , 2004, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[89]  Jing Xu,et al.  Computer Simulation of Convective and Diffusive Transport of Controlled-Release Drugs in the Vitreous Humor , 2004, Pharmaceutical Research.

[90]  Peter Wiedemann,et al.  Drug delivery systems for vitreoretinal diseases , 2004, Progress in Retinal and Eye Research.

[91]  U. Kompella,et al.  Size‐dependent disposition of nanoparticles and microparticles following subconjunctival administration , 2005, The Journal of pharmacy and pharmacology.

[92]  T. F. Patton,et al.  Physicochemical determinants of drug diffusion across the conjunctiva, sclera, and cornea. , 1987, Journal of pharmaceutical sciences.

[93]  J. V. van Meurs,et al.  Peribulbar corticosteroid injection: vitreal and serum concentrations after dexamethasone disodium phosphate injection. , 1997, American journal of ophthalmology.

[94]  M. Araie,et al.  Movement of carboxyfluorescein across the isolated rabbit iris-ciliary body. , 1994, Current eye research.

[95]  M. Marmor,et al.  Albumin movement out of the subretinal space after experimental retinal detachment. , 1995, Investigative ophthalmology & visual science.

[96]  B. Saville,et al.  Drug distribution in the vitreous humor of the human eye: the effects of aphakia and changes in retinal permeability and vitreous diffusivity. , 1997, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[97]  Esther Eljarrat-Binstock,et al.  Iontophoresis: a non-invasive ocular drug delivery. , 2006, Journal of controlled release : official journal of the Controlled Release Society.